disorder

(redirected from Schizoaffective disorder)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.
Related to Schizoaffective disorder: borderline personality disorder

disorder

[dis′ȯrd·ər]
(crystallography)
Departures from regularity in the occupation of lattice sites in a crystal containing more than one element.
References in periodicals archive ?
We describe a patient diagnosed with schizoaffective disorder with the distinction of having an absent SP and gray matter heteropia.
He has a history of schizoaffective disorder, which has been stable with haloperidol, 10 mg/d, for more than a year.
Schizoaffective Disorder has moreover demonstrated poor diagnostic stability (36%) using DSM IV consensus diagnoses assessed by psychiatrists who were blind to previous research diagnoses.
Her fourth hospitalization, in 2009, was caused by symptoms that meet the ICD criteria for a schizoaffective disorder diagnosis, maniacal episode.
The court heard that at the time of the killing, Hunter had schizoaffective disorder, which made him feel paranoid, suspicious and out of touch with reality.
People with severe mental illness such as schizophrenia, schizoaffective disorder, or bipolar disorder use a popular social media website like YouTube to provide and receive naturally occurring peer support, according to researchers at the Dartmouth Institute for Health Policy & Clinical Practice.
SZ patients with schizoaffective disorder (SAD) showed the highest level of cognitive impairment in all neurocognitive domains.
That included 9,142 psychiatric patients diagnosed with schizophrenia, bipolar disorder or schizoaffective disorder.
Peter's been diagnosed with schizoaffective disorder, and so suffers mood swings and delusional behaviour.
Reese Holley suffers from Schizoaffective Disorder, depression and anxiety.
[USPRwire, Fri Aug 09 2013] Global Markets Direct's, 'Schizoaffective Disorder - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.
Researchers note that Reviva's REFRESH trial--a randomized, double-blind, placebo-controlled, dose-ranging, global and multicenter Phase II study to assess the efficacy, safety and to|erability of the drug RP5063 --looked at 234 patients in the United States, Asia and Europe with schizophrenia and schizoaffective disorder.